Webinars

Presented by Dr. Allysa Stern, Scientist II, Cell Microsystems

Overview:
While the potential of iPSC-derived organoids in drug discovery and personalized medicine is undeniable, the existing workflows face challenges such as inefficiency, labor-intensive processes, and limitations concerning heterogeneity and throughput. Traditional organoidA 3D, self-organizing cell structure, derived from pluripotent or adult stem cells that mimic aspects of organ function and architecture. culture methods also pose difficulties in the downstream analysis of individual organoids.

Key Topics:
During this webinar, Dr. Stern will address these challenges and present innovative workflows aimed at enhancing the utility and reproducibility of iPSC-derived organoids.
• Attend this webinar to learn how to:
• Generate organoids, including clonal organoids, at scale.
• Monitor differentiation of iPSCs into organoids over time.
• Create custom assay plates of single organoids for downstream use.

This webinar recording is an excellent opportunity to gain insights into cutting-edge approaches for overcoming current limitations in iPSC-derived organoid workflows. It is followed by a Q & A session.